Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,375.20
(
-1.46%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.44
(
3.84%
)
Bitcoin
69,938.67
(
0.06%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bornfromapetridish post# 4064

Monday, 07/09/2007 12:51:28 PM

Monday, July 09, 2007 12:51:28 PM

Post# of 19309
>My best guess that the delay in reimbursement rates is because the company(s) are dealing with EU bureaucracy.<

Reimbursement for ATryn has nothing to do with the EU itself—it is up to each individual country to negotiate a deal with Leo. This is how reimbursement works in the EU countries for all prescription drugs. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today